期刊文献+

铜绿假单胞菌氨基糖苷16SrRNA甲基化酶基因分析 被引量:2

Analysis on the aminoglycosides 16S rRNA methylase genes and resistance characteristic of Pseudomonas aeruginosa
原文传递
导出
摘要 目的调查215株湖州地区临床分离铜绿假单胞菌对氨基糖苷类抗生素的耐药性和16S rRNA甲基化酶基因分布情况。方法收集2011年1月至2012年12月湖州地区临床分离铜绿假单胞菌215株,琼脂稀释法测定5种氨基糖苷类抗菌药物(庆大霉素、阿米卡星、妥布霉素、伊帕米星、奈替米星)的MIC值;PCR检测armA、rmtA、rmtB、rmtC、rmtD和npmA六种氨基糖苷类16S rRN甲基化酶基因,序列分析明确基因型。测定产16S rRNA甲基化酶菌株对常见抗菌的敏感性,并检测碳青霉烯耐药株产碳青霉烯酶情况。结果铜绿假单胞菌对异帕米星敏感率最高为81.4%,对5种氨基糖苷类抗生素全部耐药的22株菌株中,17株检出armA基因;未发现其他16S rRNA甲基化酶基因阳性菌株。17株armA阳性菌株对碳青霉烯类抗生素耐药5株(耐药率为29.4%),对头孢他啶、头孢吡肟、哌拉西林/他唑巴坦、环丙沙星耐药率均超过40%。5株碳青霉烯耐药菌株中检测到2株产VIM-2型金属碳青霉烯酶。结论铜绿假单胞菌对氨基糖苷类抗生素耐药率高,检测到16S rRNA甲基化酶基因armA。产16S rRNA甲基化酶铜绿假单胞菌耐药性强,部分菌株同时产金属碳青霉烯酶,给临床抗感染治疗及院内感染控制带来挑战。 Objective To investigate the resistance to aminoglycosides and prevalence of 16S rRNA methylases genes in Pseudomonas cteruginosa isolates isolated from a hospital in Huzhou. Methods Total of 215 isolates of Pseudornonas aeruginosa were collected from a hospitals of Huzhou, through January, 2011 to December, 2012. The minimum inhibitory concentrations (MIC) of these strains were examined by agar dilution method. Six 16S rRNA methylase genes, arrnA, rmtA, rmtB, rmtC, rmtD and nprnA, were detected by PCR. PCR products were purified and sequenced. Susceptibility of 16S rRNA methylases-producing isolates were detected, and carbapenem coding genes were detected among carbapenem-resistant strains. Results The highest susceptibility rate among the 5 antimicrobials was isepamicin, 81.4%. 17 armA-positive isolates were identified from 22 Pseudomonas aeruginosa isolates which were high-level resistance to five aminoglycosides. No other 16S rRNA methylase gene was detected. Five of the 17 annA-producing strains were resistant to earbapenem ( 29.4% ). Resistance of ceftazidime, cefepime, piperacillin/tazobactam, ciprofloxacin was all above 40%. VIM-2 gene was detect in 2 of the 5 carhapenem-resistant strains. Conclusion The resistant rate to aminoglycosides is high in Pseudomonas aeruginosa. ArmA-producing Pseudomonas aeruginosa isolates are detected in Zhejiang province.
出处 《中国微生态学杂志》 CAS CSCD 2014年第6期663-666,共4页 Chinese Journal of Microecology
基金 卫生部临床重点专科建设项目
关键词 氨基糖苷类抗生素 16S rRNA甲基化酶 铜绿假单胞菌 Aminoglycoside 16S rRNA methylases: Pseudomonas aeruginosa
  • 相关文献

参考文献14

  • 1糜祖煌,黄支密,秦玲.鲍氏不动杆菌耐药性和氨基糖苷类修饰酶、β-内酰胺酶基因研究[J].中华医院感染学杂志,2004,14(9):968-971. 被引量:136
  • 2周月清,陆开来,糜祖煌.鲍曼不动杆菌TEM基因及氨基糖苷类修饰酶基因初步研究[J].中华检验医学杂志,2005,28(2):200-202. 被引量:64
  • 3Alejandra GF,Oliverio WLi Salvador SF,et al.In vitro and in vi-vo activities of antimicrobials against Nocardia brasiliensis[J].Anti-microb Agents Chemoth,2004,48(3):832-837.
  • 4Yokoyama K,Doi Y,Yamane K,et al.Acquisition of 16S rRNAmethylase gene in Pseudomonas aeruginosa[J].Lancet 2003,362(9399):1888-1893.
  • 5GaIimand M,Courvalin P,Lambert T.Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNAmethylation[J].Antimicrob Agents Chemother,2003,47(8):2565-2571.
  • 6LeeK,Yum JH,Yong D,et al.Novel acquired metallo-beta-lacta-mase gene,bla(SIM-1),in a class I integron from Acinetobacterbaumannii clinical isolates from Korea[J].Antimicrob Agents Che-mother,2005,49(11):4485-4491.
  • 7Doi Y,Arakawa Y.16S ribosomal RNA methylation:emerging re-sistance mechanism against aminoglycosides[J].Clin Infect Dis,2007,45(1):88-94.
  • 8Wachino J,Shibayama K,Kurokawa H,et al.Novel plasmid-me-diated 16S rRNA ml A1408 methyltransferase,NpmA,found in aclinically isolated Escherichia coli strain resistant to structurally di-verse aminoglycosides[J].Antimicrob Agents Chemother,2007,51(21):4401-4409.
  • 9Kotra LP,Haddad J,Mobashery S.Aminoglycosides:perspectiveson mechanisms of action and resistance and strategies to counter re-sistance[J].Antimicrob Agent Chemother,2000,44(12):3249-3256.
  • 10Galimand M,Courvalin P,Lambert T.Plasmid-mediated high-lev-el resistance to aminoglycosides in Enterobacteriaceae due to 16SrRNA methylation[J].Antimicrob Agents Chemother,2003,47(8):2565-2571.

二级参考文献13

  • 1Vila J, Ruiz J, Navia M, et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol, 1999, 37:758-761.
  • 2Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter bs, mannli. Antimicrob Agents Chemother, 2001,45 :583-588.
  • 3Poirel L, Menuteau O, Agoli N, et al. Outbreak of extended-spectrum beta-lactamase VEB-l-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol, 2003, 41:3542-3547.
  • 4Vahaboglu H , Ozturk R, Aygun G , et al. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomia lAcinetobacter and Psoudomonas aemginosa isolates in Turkey: a nationwide multicenter study. Antimicro Agents Chemother, 1997,41:2265-2269.
  • 5Ruiz J, Navia MM, Casals C, et al. Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain. Clin Microbiol Infect, 2003,9:907-911.
  • 6www.ncbi.nlm.nih.gov/nucleotide.
  • 7Galimand M, Gerbaud G, Courvalin P. Spectinomycin resistance in Neisseria spp. due to mutations in 16S rRNA[J]. Antimicrob Agent Chemother, 2000, 44(5): 1365-1366.
  • 8Jordi V, Joaquim R, Margarita N, et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain[J]. J Clin Microbiol, 1999, 37(3): 758-761.
  • 9王辉,陈民钧,中国医院内病原菌耐药监测网.1994~2001年中国重症监护病房非发酵糖细菌的耐药变迁[J].中华医学杂志,2003,83(5):385-390. 被引量:422
  • 10陈东科,崔巧珍,胡云建.医院内不动杆菌流行现状及耐药性分析[J].中华流行病学杂志,2003,24(7):640-641. 被引量:27

共引文献172

同被引文献29

  • 1JIANG Meijie, SUN qiying, LIU Guangli. Resistance analysis of Pseudomonas aeruginosa in 2006-2010[J]. Chin J Hosp In- fect, 2012, 22(8): 1703-1704.
  • 2CHEN Junqing, CHEN Danxia, HUANG Chengang, et al. Resist- ant to imipenem in Pseudomonas aeruginosa nosocomial infection risk factors analysis[J]. Chin J Hosp Infect, 2011, 21(11) : 2212-2213.
  • 3Clinical and Laboratory Standards Institute. National Commit- tee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing[S]. Pennsylvania: NC- CLS, 2011.
  • 4Maraki S, Mavros MN, Kofteridis DP, et at. Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram- negative bacilli isolated from patients treated on surgical wards[J]. Surg Infect(Larchmt), 2012, 13(5): 326-331.
  • 5Kiiru J, Butaye P, Goddeeris BM, et al. Analysis for preva- lence and physical linkages amongst integrons, ISEcp 1, ISCR1, Tn21 and Tn7 encountered in Escherichia coli strains from hospitalized and non-hospitalized patients in Kenya during a 19-year period(1992-2011)[J]. BMC Microbiol, 2013, 13 (109): 1471-1476.
  • 6Pasca MR, Dalla Valle C, De Jesus Lopes Ribeiro AL. et al. Evaluation of fluoroquinolone resistance mechanisms in Pseud- omonas aeruginosa multidrug resistance clinical isolates[J]. Microb Drug Resist, 2012, 18(1):23-32.
  • 7XIE Yongping, LUN Xiuhong, HE Jiaying, et al. Multi-drug resistant Pseudomonas aeruginosa resistance and resistance gene detection analysis[J]. Chin J Mieroeeol, 2012, 24(4): 345-347.
  • 8HUANG Zhihui, TANG Xiaoping, Zhou Hua, et al. Pseudo- monas aeruginosa aminoglycoside 16S rRNA methylase gene a- nalysis[J]. Chin J Microecol, 2014, 26(6): 663-666.
  • 9Willcox MD. Review of resistance of ocular isolates of Pseudo- monas aeruginosa and Staphylococci from keratitis to cipro- floxacin, gentamicin and cephalosporins[J]. Clin Exp Optom, 2011, 94(2): 161-168.
  • 10Lewis GJ, Fang X, Gooeh M, et al. Decreased resistance of Pseudomonas aeruginosa with restriction of eiprofloxacin in a large teaching hospital S intensive care and intermediate care u- nits[J]. Infect Control Hosp Epidemiol, 2012, 33 (4): 368-373.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部